UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Small Cell Lung Carcinoma Cells Depend on KIF11 for Survival

International journal of molecular sciences, 2024-07, Vol.25 (13), p.7230

2024

Volltextzugriff (PDF)

Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cells

Biochemical and biophysical research communications, 2022-11, Vol.630, p.24-29

2022

Volltextzugriff (PDF)

A Newly Developed Anti-L1CAM Monoclonal Antibody Targets Small Cell Lung Carcinoma Cells

International journal of molecular sciences, 2024-08, Vol.25 (16), p.8748

2024

Volltextzugriff (PDF)

Junctional adhesion molecule 3 is a potential therapeutic target for small cell lung carcinoma

Experimental cell research, 2023-05, Vol.426 (2), p.113570-113570, Article 113570

2023

Volltextzugriff (PDF)

MCL1 inhibition enhances the efficacy of docetaxel against airway-derived squamous cell carcinoma cells

Experimental cell research, 2021-09, Vol.406 (2), p.112763-112763, Article 112763

2021

Volltextzugriff (PDF)

MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells

Lung cancer (Amsterdam, Netherlands), 2019-07, Vol.133, p.88-95

2019

Volltextzugriff (PDF)

Characterization of distal airway stem-like cells expressing N-terminally truncated p63 and thyroid transcription factor-1 in the human lung

Experimental cell research, 2018-11, Vol.372 (2), p.141-149

2018

Volltextzugriff (PDF)

BDNF Gene-Modified Mesenchymal Stem Cells Promote Functional Recovery and Reduce Infarct Size in the Rat Middle Cerebral Artery Occlusion Model

Molecular therapy, 2004-02, Vol.9 (2), p.189-197

2004

Volltextzugriff (PDF)

Dual inhibition of KIF11 and BCL2L1 induces apoptosis in lung adenocarcinoma cells

Biochemical and biophysical research communications, 2023-10, Vol.678, p.84-89

2023

Volltextzugriff (PDF)

Anthrax toxin receptor 2 is a potential therapeutic target for non-small cell lung carcinoma with MET exon 14 skipping mutations

Experimental cell research, 2022-04, Vol.413 (2), p.113078-113078, Article 113078

2022

Volltextzugriff (PDF)

Carcinoembryonic Antigen–Targeted Selective Gene Therapy for Gastric Cancer through FZ33 Fiber-Modified Adenovirus Vectors

Clinical cancer research, 2006-06, Vol.12 (12), p.3803-3813

2006

Volltextzugriff (PDF)

Epigenetic Modulation Enhances the Therapeutic Effect of Anti―IL-13Rα2 Antibody in Human Mesothelioma Xenografts

Clinical cancer research, 2011-05, Vol.17 (9), p.2819-2829

2011

Volltextzugriff (PDF)

EGFR-independent EGFR-mutant lung adenocarcinoma cells depend on Bcl-xL and MCL1 for survival

Biochemical and biophysical research communications, 2020-05, Vol.526 (2), p.417-423

2020

Volltextzugriff (PDF)

Pericyte-myofibroblast transition in the human lung

Biochemical and biophysical research communications, 2020-07, Vol.528 (2), p.269-275

2020

Volltextzugriff (PDF)

Bcl-xL gene transfer inhibits bax translocation and prolongs cardiac cold preservation time in rats

Circulation (New York, N.Y.), 2005-07, Vol.112 (1), p.76-83

2005

Volltextzugriff (PDF)

Adenoviral-delivered angiopoietin-1 reduces the infarction and attenuates the progression of cardiac dysfunction in the rat model of acute myocardial infarction

Molecular therapy, 2003-10, Vol.8 (4), p.584-592

2003

Volltextzugriff (PDF)

Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial–mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis

Laboratory investigation, 2017-03, Vol.97 (3), p.232-242

2017

Volltextzugriff (PDF)

Prolyl isomerase Pin1 promotes survival in EGFR-mutant lung adenocarcinoma cells with an epithelial–mesenchymal transition phenotype

Laboratory investigation, 2016-04, Vol.96 (4), p.391-398

2016

Volltextzugriff (PDF)

Angiotensin-converting enzyme 2 is a potential therapeutic target for EGFR-mutant lung adenocarcinoma

Biochemical and biophysical research communications, 2017-06, Vol.487 (3), p.613-618

2017

Volltextzugriff (PDF)

Survivin knockdown induces senescence in TTF‑1-expressing, KRAS-mutant lung adenocarcinomas

International journal of oncology, 2018-07, Vol.53 (1), p.33-46

2018

Volltextzugriff (PDF)

Development of a sensitive screening method for selecting monoclonal antibodies to be internalized by cells

Biochemical and biophysical research communications, 2014-11, Vol.454 (4), p.600-603

2014

Volltextzugriff (PDF)

Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model

Molecular therapy, 2005-01, Vol.11 (1), p.96-104

2005

Volltextzugriff (PDF)

Trametinib downregulates survivin expression in RB1-positive KRAS-mutant lung adenocarcinoma cells

Biochemical and biophysical research communications, 2018-06, Vol.501 (1), p.253-258

2018

Volltextzugriff (PDF)

Epigenetic Modulation Enhances the Therapeutic Effect of Anti-IL-13R alpha 2 Antibody in Human Mesothelioma Xenografts

Clinical cancer research, 2011-05, Vol.17 (9), p.2819-2829

2011

Volltextzugriff (PDF)

Epigenetic modulation enhances the therapeutic effect of anti-IL-13R(alpha)2 antibody in human mesothelioma xenografts

Clinical cancer research, 2011-05, Vol.17 (9), p.2819-2829

2011

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(46)
Berichte
(1)

Sprache

Englisch
(44)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Small Cell Lung Carcinoma Cells Depend on KIF11 for Survival

Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cells

A Newly Developed Anti-L1CAM Monoclonal Antibody Targets Small Cell Lung Carcinoma Cells

Junctional adhesion molecule 3 is a potential therapeutic target for small cell lung carcinoma

MCL1 inhibition enhances the efficacy of docetaxel against airway-derived squamous cell carcinoma cells

MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells

Characterization of distal airway stem-like cells expressing N-terminally truncated p63 and thyroid transcription factor-1 in the human lung

BDNF Gene-Modified Mesenchymal Stem Cells Promote Functional Recovery and Reduce Infarct Size in the Rat Middle Cerebral Artery Occlusion Model

Dual inhibition of KIF11 and BCL2L1 induces apoptosis in lung adenocarcinoma cells

Anthrax toxin receptor 2 is a potential therapeutic target for non-small cell lung carcinoma with MET exon 14 skipping mutations

Carcinoembryonic Antigen–Targeted Selective Gene Therapy for Gastric Cancer through FZ33 Fiber-Modified Adenovirus Vectors

Epigenetic Modulation Enhances the Therapeutic Effect of Anti―IL-13Rα2 Antibody in Human Mesothelioma Xenografts

EGFR-independent EGFR-mutant lung adenocarcinoma cells depend on Bcl-xL and MCL1 for survival

Pericyte-myofibroblast transition in the human lung

Bcl-xL gene transfer inhibits bax translocation and prolongs cardiac cold preservation time in rats

Adenoviral-delivered angiopoietin-1 reduces the infarction and attenuates the progression of cardiac dysfunction in the rat model of acute myocardial infarction

Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial–mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis

Prolyl isomerase Pin1 promotes survival in EGFR-mutant lung adenocarcinoma cells with an epithelial–mesenchymal transition phenotype

Angiotensin-converting enzyme 2 is a potential therapeutic target for EGFR-mutant lung adenocarcinoma

Survivin knockdown induces senescence in TTF‑1-expressing, KRAS-mutant lung adenocarcinomas

Development of a sensitive screening method for selecting monoclonal antibodies to be internalized by cells

Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model

Trametinib downregulates survivin expression in RB1-positive KRAS-mutant lung adenocarcinoma cells

Epigenetic Modulation Enhances the Therapeutic Effect of Anti-IL-13R alpha 2 Antibody in Human Mesothelioma Xenografts

Epigenetic modulation enhances the therapeutic effect of anti-IL-13R(alpha)2 antibody in human mesothelioma xenografts

Suchergebnisse filtern